Breast cancer is the number one cancer among women: more than 2 million cases were diagnosed worldwide in 2022. It is also ...

Oxford researchers have discovered why some patients benefit from the most commonly used advanced therapy in autoimmune diseases and some do not.

Analysis - Breast cancer is the number one cancer among women: more than 2 million cases were diagnosed worldwide in 2022. It is also particularly challenging to treat. Physiologist Anna-Mart ...

Department of Physiology, Division of Life Science, Faculty of Medicine, Osaka Medical and Pharmaceutical University, Takatsuki, Japan ...

SonoThera to Present at ASN Kidney Week 2024 Demonstrating the Potential of Novel Nonviral Ultrasound-Mediated Gene Therapy ...

In a world first, researchers have mapped the cellular dynamics following treatment with the most commonly used advanced ...

Endocrine Neoplasia Translational Research Center, Division of Endocrinology, Diabetes and Metabolism, Chaim Sheba Medical Center, and Tel Aviv University Faculty of Medicine, Ramat Gan, Israel This ...

Both Wnt and BMP signaling regulate maintenance of Lgr5+ intestinal stem cells, but their interplay remains incompletely ...

London-based GSK is crossing the pond to form a new lung disease research collaboration with Boston scientists. | ...

The European Medicines Agency has recommended Korjuny for the treatment of patients with intraperitoneal malignant ascites.

Researchers from the Center for Regenerative Medicine (CReM) at Boston University and (BMC) have announced a new collaboration with the global biopharma company GSK to advance innovative research ...